Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

582 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Triple combination therapy comprising osimertinib, an AXL inhibitor, and an FGFR inhibitor improves the efficacy of EGFR-mutated non-small cell lung cancer.
Nakamura R, Yamada T, Tokuda S, Morimoto K, Katayama Y, Matsui Y, Hirai S, Ishida M, Kawachi H, Sawada R, Tachibana Y, Osoegawa A, Horinaka M, Sakai T, Yasuhiro T, Kozaki R, Yano S, Takayama K. Nakamura R, et al. Among authors: tachibana y. Cancer Lett. 2024 Aug 28;598:217124. doi: 10.1016/j.canlet.2024.217124. Epub 2024 Jul 24. Cancer Lett. 2024. PMID: 39059573 Free article.
AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells.
Morimoto K, Yamada T, Hirai S, Katayama Y, Fukui S, Sawada R, Tachibana Y, Matsui Y, Nakamura R, Ishida M, Kawachi H, Kunimasa K, Sasaki T, Nishida M, Furuya N, Watanabe S, Shiotsu S, Nishioka N, Horinaka M, Sakai T, Uehara H, Yano S, Son BK, Tokuda S, Takayama K. Morimoto K, et al. Among authors: tachibana y. Cancer Lett. 2024 Apr 10;587:216692. doi: 10.1016/j.canlet.2024.216692. Epub 2024 Feb 9. Cancer Lett. 2024. PMID: 38342232 Free article.
Depth of response and treatment outcomes of immune checkpoint inhibitor-based therapy in patients with advanced non-small cell lung cancer and high PD-L1 expression: An exploratory analysis of retrospective multicenter cohort.
Tachibana Y, Morimoto K, Yamada T, Kawachi H, Tamiya M, Negi Y, Goto Y, Nakao A, Shiotsu S, Tanimura K, Takeda T, Okada A, Harada T, Date K, Chihara Y, Hasegawa I, Tamiya N, Katayama Y, Nishioka N, Iwasaku M, Tokuda S, Kijima T, Takayama K. Tachibana Y, et al. Invest New Drugs. 2024 Oct;42(5):538-546. doi: 10.1007/s10637-024-01467-7. Epub 2024 Aug 21. Invest New Drugs. 2024. PMID: 39168900
Asian Neonatal Network Collaboration (AsianNeo): a study protocol for international collaborative comparisons of health services and outcomes to improve quality of care for sick newborn infants in Asia - survey, cohort and quality improvement studies.
Isayama T, Miyake F, Rohsiswatmo R, Dewi R, Ozawa Y, Tomotaki S, Morisaki N, Chee SC, Neoh SH, Imperial MLS, Velasco BAE, Chang YS, Cho SJ, Youn Y, Quek BH, Poon WB, Amin Z, Jayaratne K, Kumara S, Lin YJ, Chang JH, Lin HY, Lin MC, Nuntnarumit P, Ngerncham S, Prempunpong C, Prempraphan P, Supapannachart S, Kusuda S; Asian Neonatal Network Collaboration (AsianNeo). Isayama T, et al. BMJ Open. 2024 Jul 13;14(7):e082712. doi: 10.1136/bmjopen-2023-082712. BMJ Open. 2024. PMID: 39388526 Free PMC article.
Cross-sectional association between high-sensitivity C-reactive protein and cognitive function in community-dwelling older adults: the SONIC study.
Hosokawa M, Kabayama M, Godai K, Akagi Y, Tachibana Y, Gondo Y, Yasumoto S, Masui Y, Hirata T, Ishizaki T, Akasaka H, Takeya Y, Takami Y, Yamamoto K, Kitamura M, Ikebe K, Arai Y, Rakugi H, Kamide K. Hosokawa M, et al. Among authors: tachibana y. BMC Geriatr. 2024 Sep 12;24(1):756. doi: 10.1186/s12877-024-05354-x. BMC Geriatr. 2024. PMID: 39266972 Free PMC article.
Relationship between respiratory function assessed by spirometry and mild cognitive impairment among community-dwelling older adults.
Tachibana Y, Godai K, Kabayama M, Akagi Y, Kido M, Hosokawa M, Akasaka H, Takami Y, Yamamoto K, Yasumoto S, Masui Y, Ikebe K, Arai Y, Ishizaki T, Gondo Y, Kamide K. Tachibana Y, et al. Geriatr Gerontol Int. 2024 Oct;24(10):1001-1007. doi: 10.1111/ggi.14962. Epub 2024 Aug 20. Geriatr Gerontol Int. 2024. PMID: 39162320 Free PMC article.
Initial AXL and MCL-1 inhibition contributes to abolishing lazertinib tolerance in EGFR-mutant lung cancer cells.
Matsui Y, Yamada T, Katayama Y, Hirai S, Sawada R, Tachibana Y, Ishida M, Kawachi H, Nakamura R, Nishioka N, Morimoto K, Iwasaku M, Horinaka M, Sakai T, Tokuda S, Takayama K. Matsui Y, et al. Among authors: tachibana y. Cancer Sci. 2024 Oct;115(10):3333-3345. doi: 10.1111/cas.16292. Epub 2024 Jul 22. Cancer Sci. 2024. PMID: 39039802 Free PMC article.
582 results